-
Promising path found for COVID-19 therapeutics
worldpharmanews
June 17, 2020
A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein - providing a promising path for new COVID-19 therapeutics.
-
A protein that helps to fight viruses can also block lung damage repair
worldpharmanews
June 17, 2020
Researchers at the Francis Crick Institute have found that a protein which is initially helpful in the body's immune response to a virus, can later interfere with the repair of lung tissue.
-
Local authorities in England get funding for test and trace
pharmatimes
June 16, 2020
The government has confirmed a funding stream of £300 million for local authorities in England to help facilitate COVID-19 action plans including the new track and trace service in their areas.
-
Scientists identify targets for COVID-19 vaccine using cancer immunotherapy tools
worldpharmanews
June 10, 2020
Cancer researchers at Children's Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine...
-
New coronavirus losing potency, top Italian doctor says
expresspharma
June 02, 2020
Italy has the third highest death toll in the world from COVID-19, with 33,415 people dying since the outbreak came to light on Feb. 21. It has the sixth highest global tally of cases at 233,019.
-
Chinese, US scientists identify bacterial secreted proteins that can inactivate coronavirus
expresspharma
May 27, 2020
This can provide a future avenue for the development of broad-spectrum antiviral drugs that might reduce the clinical burden caused by emerging viral diseases, according to a paper released on bioRxiv.
-
People with diabetes at higher risk of amid pandemic
pharmatimes
May 21, 2020
NHS England is calling on people with diabetes to access the help available to them after new research showed that those living with the condition are at significantly higher risk of dying with COVID-19.
-
Oxford University’s Covid-19 vaccine shows promise in animal study
pharmaceutical-technology
May 18, 2020
The University of Oxford in the UK has reported positive findings of its Covid-19 vaccine candidate in a small preclinical study involving six monkeys.
-
Demand for immunity products to be sustained long-term: SIRIO
expresspharma
May 12, 2020
Consumers are also purchasing products that strengthen their respiratory and cardiovascular systems, with Omega-3 fatty acids and antioxidants – that may protect against oxidative stress.
-
Open Science: Key to combat zoonosis
expresspharma
May 07, 2020
“There are decades where nothing happens, and there are weeks where decades happen.” These words by Russian revolutionary, Vladimir Lenin describes the current scenario to a ‘T’.